FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048741008> ?p ?o ?g. }

• W3048741008 endingPage "e20667" @default.
• W3048741008 startingPage "e20667" @default.
• W3048741008 abstract "Background Access to physical activity among youth with spina bifida (SB) is much lower than it is for children without disability. Enjoyable home-based exercise programs are greatly needed. Objective Our objective is to examine the feasibility of a virtual reality (VR) active video gaming system (ie, bundle of consumer-available equipment) to meet US physical activity guidelines in two youth with SB. Methods Two youth with SB—a 12-year-old female and a 13-year-old male; both full-time wheelchair users—participated in a brief, 4-week exercise program using a popular VR head-mounted display: Oculus Quest (Facebook Technologies). The system included a Polar H10 (Polar Canada) Bluetooth heart rate monitor, a no-cost mobile phone app (VR Health Exercise Tracker [Virtual Reality Institute of Health and Exercise]), and 13 games. The intervention protocol was conducted entirely in the homes of the participants due to the coronavirus disease 2019 (COVID-19) pandemic. The VR system was shipped to participants and they were instructed to do their best to complete 60 minutes of moderate-intensity VR exercise per day. Exercise duration, intensity, and calories expended were objectively monitored and recorded during exercise using the heart rate monitor and a mobile app. Fatigue and depression were measured via self-report questionnaires at pre- and postintervention. Participants underwent a semistructured interview with research staff at postintervention. Results Across the intervention period, the total average minutes of all exercise performed each week for participants 1 and 2 were 281 (SD 93) and 262 (SD 55) minutes, respectively. The total average minutes of moderate-intensity exercise performed per week for participants 1 and 2 were 184 (SD 103) (184/281, 65.4%) and 215 (SD 90) (215/262, 82.1%) minutes, respectively. One participant had a reduction in their depression score, using the Quality of Life in Neurological Disorders (Neuro-QoL) test, from baseline to postintervention, but no other changes were observed for fatigue and depression scores. Participants reported that the amount of exercise they completed was far higher than what was objectively recorded, due to usability issues with the chest-worn heart rate monitor. Participants noted that they were motivated to exercise due to the enjoyment of the games and VR headset as well as support from a caregiver. Conclusions This study demonstrated that two youth with SB who used wheelchairs could use a VR system to independently and safely achieve exercise guidelines at home. Study findings identified a promising protocol for promoting exercise in this population and this warrants further examination in future studies with larger samples." @default.
• W3048741008 created "2020-08-18" @default.
• W3048741008 creator A5026422721 @default.
• W3048741008 creator A5054433397 @default.
• W3048741008 creator A5057070513 @default.
• W3048741008 creator A5058735637 @default.
• W3048741008 creator A5060861470 @default.
• W3048741008 creator A5082062479 @default.
• W3048741008 creator A5087178014 @default.
• W3048741008 creator A5088442254 @default.
• W3048741008 date "2020-09-03" @default.
• W3048741008 modified "2023-10-18" @default.
• W3048741008 title "Feasibility of a Commercially Available Virtual Reality System to Achieve Exercise Guidelines in Youth With Spina Bifida: Mixed Methods Case Study" @default.
• W3048741008 cites W1806789883 @default.
• W3048741008 cites W1916007311 @default.
• W3048741008 cites W1916571204 @default.
• W3048741008 cites W1966023878 @default.
• W3048741008 cites W1989014651 @default.
• W3048741008 cites W1992395191 @default.
• W3048741008 cites W2000227620 @default.
• W3048741008 cites W2026420344 @default.
• W3048741008 cites W2029580057 @default.
• W3048741008 cites W2061814941 @default.
• W3048741008 cites W2067801379 @default.
• W3048741008 cites W2075300995 @default.
• W3048741008 cites W2083992357 @default.
• W3048741008 cites W2092722444 @default.
• W3048741008 cites W2111897797 @default.
• W3048741008 cites W2145323947 @default.
• W3048741008 cites W2156739230 @default.
• W3048741008 cites W2218372478 @default.
• W3048741008 cites W2262422562 @default.
• W3048741008 cites W2289587231 @default.
• W3048741008 cites W2344447430 @default.
• W3048741008 cites W2415424991 @default.
• W3048741008 cites W2592001525 @default.
• W3048741008 cites W2597782088 @default.
• W3048741008 cites W2606029999 @default.
• W3048741008 cites W2732421904 @default.
• W3048741008 cites W2889782755 @default.
• W3048741008 cites W2938169034 @default.
• W3048741008 cites W2939380501 @default.
• W3048741008 cites W2948243013 @default.
• W3048741008 cites W2999454565 @default.
• W3048741008 cites W3010478948 @default.
• W3048741008 cites W3034750382 @default.
• W3048741008 cites W4250098481 @default.
• W3048741008 doi "https://doi.org/10.2196/20667" @default.
• W3048741008 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7499165" @default.
• W3048741008 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32880577" @default.
• W3048741008 hasPublicationYear "2020" @default.
• W3048741008 type Work @default.
• W3048741008 sameAs 3048741008 @default.
• W3048741008 citedByCount "20" @default.
• W3048741008 countsByYear W30487410082021 @default.
• W3048741008 countsByYear W30487410082022 @default.
• W3048741008 countsByYear W30487410082023 @default.
• W3048741008 crossrefType "journal-article" @default.
• W3048741008 hasAuthorship W3048741008A5026422721 @default.
• W3048741008 hasAuthorship W3048741008A5054433397 @default.
• W3048741008 hasAuthorship W3048741008A5057070513 @default.
• W3048741008 hasAuthorship W3048741008A5058735637 @default.
• W3048741008 hasAuthorship W3048741008A5060861470 @default.
• W3048741008 hasAuthorship W3048741008A5082062479 @default.
• W3048741008 hasAuthorship W3048741008A5087178014 @default.
• W3048741008 hasAuthorship W3048741008A5088442254 @default.
• W3048741008 hasBestOaLocation W30487410081 @default.
• W3048741008 hasConcept C154945302 @default.
• W3048741008 hasConcept C15744967 @default.
• W3048741008 hasConcept C159110408 @default.
• W3048741008 hasConcept C1862650 @default.
• W3048741008 hasConcept C187212893 @default.
• W3048741008 hasConcept C194969405 @default.
• W3048741008 hasConcept C2778478650 @default.
• W3048741008 hasConcept C2780665704 @default.
• W3048741008 hasConcept C41008148 @default.
• W3048741008 hasConcept C71924100 @default.
• W3048741008 hasConcept C99508421 @default.
• W3048741008 hasConceptScore W3048741008C154945302 @default.
• W3048741008 hasConceptScore W3048741008C15744967 @default.
• W3048741008 hasConceptScore W3048741008C159110408 @default.
• W3048741008 hasConceptScore W3048741008C1862650 @default.
• W3048741008 hasConceptScore W3048741008C187212893 @default.
• W3048741008 hasConceptScore W3048741008C194969405 @default.
• W3048741008 hasConceptScore W3048741008C2778478650 @default.
• W3048741008 hasConceptScore W3048741008C2780665704 @default.
• W3048741008 hasConceptScore W3048741008C41008148 @default.
• W3048741008 hasConceptScore W3048741008C71924100 @default.
• W3048741008 hasConceptScore W3048741008C99508421 @default.
• W3048741008 hasIssue "3" @default.
• W3048741008 hasLocation W30487410081 @default.
• W3048741008 hasLocation W30487410082 @default.
• W3048741008 hasOpenAccess W3048741008 @default.
• W3048741008 hasPrimaryLocation W30487410081 @default.
• W3048741008 hasRelatedWork W2041321140 @default.
• W3048741008 hasRelatedWork W2072496892 @default.
• W3048741008 hasRelatedWork W2083209801 @default.
• W3048741008 hasRelatedWork W2151635818 @default.

• next